Company: SCLXW
Filing Date: 2025-08-04
Form Type: S-1
Source: 0001193125-25-172703
Chunk: 564

Company: Scilex Holding Co
Filing Date: 2025-08-04
Form: S-1
Chunk 564
---
b Effective Date and continues until expiration of the last to expire Licensed Patents (as defined therein), unless earlier terminated (the “Elyxyb License Term”). F-71

**4. Fair Value Measurements**

The following table presents the Company’s financial assets and liabilities that are measured at fair value on a recurring basis and the level of inputs used in such measurements (in thousands):

|                                          |     | March 31, 2025 |        |     |                                        |   |     |                                           |   |     |                                        |        |
|:-----------------------------------------|:----|:---------------|-------:|:----|:---------------------------------------|:--|:----|:------------------------------------------|:--|:----|:---------------------------------------|-------:|
|                                          |     | Balance        |        |     | Quoted Pricesin ActiveMarkets(Level 1) |   |     | SignificantOtherObservableInputs(Level 2) |   |     | SignificantUnobservableInputs(Level 3) |        |
| Liabilities                              |     |                |        |     |                                        |   |     |                                           |   |     |                                        |        |
| Oramed Note                              |     | $              | 14,962 |     | $                                      | — |     | $                                         | — |     | $                                      | 14,962 |
| Tranche B Notes                          |     |                | 24,480 |     |                                        | — |     |                                           | — |     |                                        | 24,480 |
| Purchased revenue liability              |     |                |  7,300 |     |                                        | — |     |                                           | — |     |                                        |  7,300 |
| Derivative liabilities                   |     |                |  7,894 |     |                                        | — |     |                                           | — |     |                                        |  7,894 |
| Other long-term liabilities              |     |                |    155 |     |                                        | — |     |                                           | — |     |                                        |    155 |
| Total liabilities measured at fair value |     | $              | 54,791 |     | $                                      | — |     | $                                         | — |     | $                                      | 54,791 |

|                                          |     | December 31, 2024 |        |     |                                        |   |     |                                           |   |     |                                        |        |
|:-----------------------------------------|:----|:------------------